Matches in SemOpenAlex for { <https://semopenalex.org/work/W3212444837> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W3212444837 abstract "Abstract Background: Bruton ’ s tyrosine kinase inhibitor ibrutinib has revolutionized the treatment of chronic lymphocytic leukemia (CLL). Although ibrutinib is a highly effective drug, continuous treatment is required to maintain remission, which may lead to acquired ibrutinib resistance. Early detection of acquired resistance preceding clinical disease progression is an important issue. This is why our aim was to investigate several phenotypic markers on CLL cells to reveal changes in their expression during ibrutinib treatment in sensitive and clinically resistant patients. Materials and methods: In our study 28 (treatment naive, ibrutinib sensitive, clinically ibrutinib resistant) peripheral blood (PB), and 6 paired PB and bone marrow (BM) samples from CLL patients were examined. The expression of several surface markers (CD69, CD184, CD86, CD185, CD27) was assessed by flow cytometry in each sample. Furthermore, the presence of the BTK C481S resistance mutation was tested using digital droplet PCR (ddPCR) in samples from ibrutinib sensitive and resistant cases. In addition, we investigated the changes of CLL cells ’ phenotype during ibrutinib treatment in one patient with acquired ibrutinib resistance. Results: We found that the expression of CD27 decreased during ibrutinib therapy but increased again at the onset of clinical resistance. Expressions of CD69 and CD86 were also elevated at the onset of clinical ibrutinib resistance. Furthermore, the expression of CD86 showed correlation between PB and BM samples. Relapsed cases with high CD86 expression were positive for BTK C481S mutation. In addition, our prospective study showed that the increases in the expression of CD27, CD69 and CD86 were detectable up to several months before the onset of clinical resistance. Conclusion: Our research suggests that the flow cytometric measurements of certain markers, especially CD86, may predict development of ibrutinib resistance, however, confirmatory experiments are still required. Monitoring CD86 expression on peripheral blood CLL cells during ibrutinib treatment may become a potential new method to detect acquired ibrutinib resistance in the near future." @default.
- W3212444837 created "2021-11-22" @default.
- W3212444837 creator A5000520938 @default.
- W3212444837 creator A5004119608 @default.
- W3212444837 creator A5008613923 @default.
- W3212444837 creator A5018199423 @default.
- W3212444837 creator A5022994128 @default.
- W3212444837 creator A5028913523 @default.
- W3212444837 creator A5044796563 @default.
- W3212444837 creator A5046052427 @default.
- W3212444837 creator A5046619130 @default.
- W3212444837 creator A5049774064 @default.
- W3212444837 creator A5056371539 @default.
- W3212444837 creator A5059610099 @default.
- W3212444837 creator A5063244357 @default.
- W3212444837 creator A5064509930 @default.
- W3212444837 creator A5066034218 @default.
- W3212444837 creator A5068998408 @default.
- W3212444837 creator A5074843807 @default.
- W3212444837 creator A5089495375 @default.
- W3212444837 creator A5091224882 @default.
- W3212444837 date "2021-11-15" @default.
- W3212444837 modified "2023-10-18" @default.
- W3212444837 title "Detection of emerging ibrutinib resistance by flow cytometry in patients with chronic lymphocytic leukemia" @default.
- W3212444837 doi "https://doi.org/10.21203/rs.3.rs-1046046/v1" @default.
- W3212444837 hasPublicationYear "2021" @default.
- W3212444837 type Work @default.
- W3212444837 sameAs 3212444837 @default.
- W3212444837 citedByCount "0" @default.
- W3212444837 crossrefType "posted-content" @default.
- W3212444837 hasAuthorship W3212444837A5000520938 @default.
- W3212444837 hasAuthorship W3212444837A5004119608 @default.
- W3212444837 hasAuthorship W3212444837A5008613923 @default.
- W3212444837 hasAuthorship W3212444837A5018199423 @default.
- W3212444837 hasAuthorship W3212444837A5022994128 @default.
- W3212444837 hasAuthorship W3212444837A5028913523 @default.
- W3212444837 hasAuthorship W3212444837A5044796563 @default.
- W3212444837 hasAuthorship W3212444837A5046052427 @default.
- W3212444837 hasAuthorship W3212444837A5046619130 @default.
- W3212444837 hasAuthorship W3212444837A5049774064 @default.
- W3212444837 hasAuthorship W3212444837A5056371539 @default.
- W3212444837 hasAuthorship W3212444837A5059610099 @default.
- W3212444837 hasAuthorship W3212444837A5063244357 @default.
- W3212444837 hasAuthorship W3212444837A5064509930 @default.
- W3212444837 hasAuthorship W3212444837A5066034218 @default.
- W3212444837 hasAuthorship W3212444837A5068998408 @default.
- W3212444837 hasAuthorship W3212444837A5074843807 @default.
- W3212444837 hasAuthorship W3212444837A5089495375 @default.
- W3212444837 hasAuthorship W3212444837A5091224882 @default.
- W3212444837 hasBestOaLocation W32124448371 @default.
- W3212444837 hasConcept C126322002 @default.
- W3212444837 hasConcept C143998085 @default.
- W3212444837 hasConcept C170493617 @default.
- W3212444837 hasConcept C203014093 @default.
- W3212444837 hasConcept C2777938653 @default.
- W3212444837 hasConcept C2778461978 @default.
- W3212444837 hasConcept C2779878957 @default.
- W3212444837 hasConcept C42362537 @default.
- W3212444837 hasConcept C502942594 @default.
- W3212444837 hasConcept C553184892 @default.
- W3212444837 hasConcept C71924100 @default.
- W3212444837 hasConcept C90059517 @default.
- W3212444837 hasConceptScore W3212444837C126322002 @default.
- W3212444837 hasConceptScore W3212444837C143998085 @default.
- W3212444837 hasConceptScore W3212444837C170493617 @default.
- W3212444837 hasConceptScore W3212444837C203014093 @default.
- W3212444837 hasConceptScore W3212444837C2777938653 @default.
- W3212444837 hasConceptScore W3212444837C2778461978 @default.
- W3212444837 hasConceptScore W3212444837C2779878957 @default.
- W3212444837 hasConceptScore W3212444837C42362537 @default.
- W3212444837 hasConceptScore W3212444837C502942594 @default.
- W3212444837 hasConceptScore W3212444837C553184892 @default.
- W3212444837 hasConceptScore W3212444837C71924100 @default.
- W3212444837 hasConceptScore W3212444837C90059517 @default.
- W3212444837 hasLocation W32124448371 @default.
- W3212444837 hasLocation W32124448372 @default.
- W3212444837 hasOpenAccess W3212444837 @default.
- W3212444837 hasPrimaryLocation W32124448371 @default.
- W3212444837 hasRelatedWork W1780111622 @default.
- W3212444837 hasRelatedWork W1982769358 @default.
- W3212444837 hasRelatedWork W2006528910 @default.
- W3212444837 hasRelatedWork W2172629347 @default.
- W3212444837 hasRelatedWork W2577781255 @default.
- W3212444837 hasRelatedWork W3174994842 @default.
- W3212444837 hasRelatedWork W3212253138 @default.
- W3212444837 hasRelatedWork W4283325082 @default.
- W3212444837 hasRelatedWork W4362593813 @default.
- W3212444837 hasRelatedWork W2475047365 @default.
- W3212444837 isParatext "false" @default.
- W3212444837 isRetracted "false" @default.
- W3212444837 magId "3212444837" @default.
- W3212444837 workType "article" @default.